course materials

1. Women’s And Men’s Health/Infections Discussion
Women’s And Men’s Health/Infections DiscussionWomen’s And Men’s Health/Infections
DiscussionReview the resources for this module and reflect on the different health needs
and body systems presented.Review your peers case studies from Week 9.Consider how
you will practice critical decision making for prescribing appropriate drugs and treatment
to address the complex patient health needs in the patient case study you selected.By Day 6
of Week 10Read a selection of your colleagues’ responses from Week 9 and respond to at
least two of your colleagues on two different days who were assigned a different patient
case study, and provide recommendations for alternative drug treatments to address the
patient’s pathophysiology. Be specific and provide examples.ORDER NOW FOR
CUSTOMIZED, PLAGIARISM-FREE PAPERSCase Study Week 9 DiscussionHH is a 68-year-old
male admitted to the medical ward with community-acquired pneumonia for the past three
days. His past medical history PMH is significant for chronic obstructive pulmonary disease
(COPD), hyperlipidemia diabetes. He remains on an empiric antibiotic, including Ceftriaxone
1 gram IV (3 days) and azithromycin 500 mg IV daily (day 3). Since admission, his clinical
status has improved, with decreased oxygen requirements. He is not tolerating a diet at this
time, with complaints of nausea and vomiting.Height 5ft “8” inches, weight: 89 KgAllergies:
Penicillin (Rash)IntroductionSubsequently, community-acquired pneumonia is the most
common infectious disease and is a significant cause of mortality and morbidity globally. In
this case scenario, the patient has a past medical history of Chronic Obstructive Pulmonary
Disease, which predisposed the patient to community-acquired pneumonia. Pneumonia is
the most common infectious disease condition and significantly affects individuals with
chronic respiratory disorders. According to Restrepo, Sibila and, Anzueto,2018 reveal COPD
patients are more susceptible to develop pneumonia base on their clinical characteristics,
such a having chronic bronchitis with present mucus production presence of potentially
pathogenic bacteria in the airway. Given the prevalence of chronic disease, nurse
practitioners must be prepared to manage patient acute care needs in conjunction with
chronic conditions. Hence, the purpose of this discussion is to explain the treatment
regimen recommendation for treating the patient, which includes the pharmacotherapeutic
of choice. Also, it will explain the patient education strategy for assisting with management.
Women’s And Men’s Health/Infections DiscussionIdentified bacteria associated with
Community-Acquired Pneumonia (CPA) include Streptococcus pneumoniae, Haemophilus
influenza, Moraxella catarrhalis, and others. In treating the patient’s pneumonia, it is
essential to utilize an antibiotic to eradicate the specific bacteria. Firstly, determining the

2. type of organism associated with the diagnosis will provide a concise vision of the
appropriate pharmacotherapy needed for the treatment regimen. In selecting the antibiotic,
the practitioner wants to ensure that the medication choice is a narrow or broad-spectrum
based on the microorganism identified with a holistic approach. According to Rosenthal and
Burchum,2021 a prime rule of antimicrobial therapy is to match the drug with the bug; the
drug should be active against known or suspected pathogens, but its spectrum should be no
broader than required. The patient noted with an allergy to penicillin, and Ceftriaxone is a
third-generation cephalosporin that is contraindicated in patients with PCN allergy
(Davis,2021). Hence patient appears to tolerate the medication without reaction.
Azithromycin is a macrolide and is recommended for respiratory infection initial dose of
500 mg the 250 mg for the remaining four days (Davis,2021).Adding an antiemetic such as
Zofran (Ondansetron) will alleviate nausea and vomiting; also, it is feasible to add
corticosteroids for inflammation in the lungs concurrently monitor patient blood sugar
closely. Consequently, nausea and vomiting will lead to dehydration; therefore, IV fluids
should be added if no contraindications.In treating the patient in an inpatient environment,
acute illness can require an assertive eye for the care of their longstanding health condition.
Ensuring that we properly treat acute illness while doing our best not to exacerbate chronic
illness is fundamental in providing competent care. The practitioner must consider the
patient holistically and not just the presented
issues.ReferenceRestrepo,M.,Sibila,O.,&Anzueto,A.,(2018). Pneumonia in patients with
Chronic Obstructive Pulmonary Disease. Vol. 81(3). P 197.DOI 10.4046/trd.2018.0030.
https://www.ncbi.nlm.nih.gov/PMC/articles/PMC6030662Rosenthal. L.D.Burchum,
J.R.(2021). Lehn’s pharmacotherapeutics for advanced practice nurses and physician
Assistants (2nd ed.) Elsevier.Up-to-Date Drug Information. Davis’s Drug Guide Online
+App/ DrugGuide.com(2021).https://www,drugguide.com/ddo?svar=c%7Crc Dayanys
MirabetThis patient is A 46-year-old, 230lb woman with a family history of breast cancer.
She is up to date on yearly mammograms. She has a history of HTN. She complains of hot
flushing, night sweats, and genitourinary symptoms. She had felt well until 1 month ago and
she presented to her gynecologist for her annual gyn examination and to discuss her
symptoms. She has a history of ASCUS about 5 years ago on her pap, other than that, Pap
smears have been normal. Home medications are Norvasc 10mg qd and HCTZ 25mg qd. Her
BP today is 150/90. She has regular monthly menstrual cycles. Her LMP was 1 month
ago.After comprehensive evaluation of the case study, it is evident that patient is
experiencing an earlier phase of menopausal transition. Because of her age of 46, the
woman could be experiencing premenopausal. Night sweats, hot flushing, and high blood
pressure are the most common symptoms. Menopause usually begins about the age of 51 or
52. However, 95% of all women normally start their menopause between the ages of 45 and
55 years. This is one of her needs which should be considered by the healthcare provider.
The patient has a family history of breast cancer and abnormal Pap smear about 5 years
ago. The patient may be worried that the current symptoms may associate with cancer. The
patient also needs treatment due to her elevated high blood pressure.A hormone
replacement medicine will not be prescribed because the patient’s menstrual cycle is still
normal. However, if the symptoms get more severe. I would start her on Selective Serotonin

3. Reuptake Inhibitor (SSRI) or Serotonin and norepinephrine reuptake inhibitors (SNRI). To
treat the hot flashes, Escitalopram which is an SSRI will be administered (Rosenthal &
Burchum, 2018). The patient should, however, be monitored since the drug has a risk of
sexual dysfunction. I would also recommend Venlafaxine SNRI. However, I would first
administer escitalopram since the patient is currently under Hypertension treatment thus
may suffer dose dependent diastolic hypertension (Rosenthal & Burchum, 2018). The North
American Menopause Society developed a guideline that should be utilized by women who
are 45 years and above. Nonetheless since the patient is not experiencing severe hot flashes,
it advisable not to prescribe anything but just monitor the patient’s symptoms and progress
(Manson et al., 2015).I will alter the existing drug regimen due to the patient’s history of
hypertension and current medications. I’m going to continue her hydrochlorothiazide. I will,
however, stop giving Norvasc and start the patient on metoprolol. As a beta blocker,
metoprolol lowers heart rate, contraction force, and conduction velocity through the AV
node. The education strategy that I would recommend include lifestyle modifications such
as yoga, exercise and lowered intake of caffeine. This modification will reduce hot flushes
and night sweating. The pre-menopausal symptoms may also be reduced by using
Acupressure, herbal medicine and homeopathy (Birkhaeuser, & Genazzani, 2018).Women’s
And Men’s Health/Infections DiscussionReferencesBirkhaeuser, M., & Genazzani, A. R.
(Eds.). (2018). Pre-Menopause, Menopause and Beyond: Volume 5: Frontiers in
Gynecological Endocrinology. Springer.Manson, J. E., Ames, J. M., Shapiro, M., Gass, M. L.,
Shifren, J. L., Stuenkel, C. A., & Schnatz, P. F. (2015). Algorithm and mobile app for
menopausal symptom management and hormonal/non-hormonal therapy decision making:
a clinical decision-support tool from The North American Menopause Society. Menopause,
22(3), 247-253.Rosenthal, L., & Burchum, J. (2018). Lehnes Pharmacotherapeutics for Nurse
Practitioners and Physicians Assistants. Elsevier Health Sciences.